Skip to main content
Not Found
Digital Seminar

2-Day Psychopharmacology Course for Mental Health Clinicians


Faculty:
Susan Marie, PhD, PMHNP, CARN-AP
Duration:
11 Hours 59 Minutes
Format:
Audio and Video
Copyright:
Aug 26, 2019
Product Code:
POS055105
Media Type:
Digital Seminar
Access:
Never expires.


Description

Clients taking psychotropic medications need an advocate who can help them make sense of the whirlwind of information regarding what drugs are good for what conditions, potentially dangerous side effects and adverse reactions, and possible alternative treatments.

They need someone who can not only effectively communicate vital information to them but can also collaborate with prescribers to determine the best course of action to take.

Simply put, these clients need you, and so you need this current and comprehensive training in psychopharmacology.

As a licensed psychiatric nurse practitioner with full independent prescriptive practice, Susan Marie, PHD, PMHNP, CARN-NP has the expertise necessary to guide you through the newest advances in psychopharmacology and contemporary trends in medication management.

You will get the advantage of an intimate, in-depth look at the key issues from a vantage point that understands the experiences of clients, mental health professionals, and prescribers.

Susan’s engaging presentation includes many take home “pearls” you can use to teach your clients about their medications and how to protect them from concerning, dangerous or adverse effects.

You will find this recording to have the most up-to-date medication information and how to use it most effectively with your clients.

CPD


CPD
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 12.5 hours CPD for points calculation by your association.

Handouts

Faculty

Susan Marie, PhD, PMHNP, CARN-AP's Profile

Susan Marie, PhD, PMHNP, CARN-AP Related seminars and products

Clinical Associate Professor


Susan Marie, PhD, PMHNP, CARN-AP, a licensed psychiatric nurse practitioner with full independent prescriptive practice and certification in addictions, brings to you over 30 years of clinical experience with highly vulnerable clients with suicidality, co-occurring addiction, homelessness, serious mental illnesses, traumatic brain injuries, and persistent pain conditions. She is noted for her “pearls and pitfalls” of psychopharmacology.  Her passions are radical respect for people with serious mental illnesses & addictions, excellence in psychopharmacology, and integrating psychotherapeutic interventions for clients with PTSD, addictions and chronic pain.

Dr. Marie is Senior Clinical Director for Behavioral Health at Old Town Clinic, Central City Concern and Associate Professor at Oregon Health and Science University in Portland, Oregon.  She teaches nationally on psychopharmacology as well as suicide assessment and intervention. 

 

Speaker Disclosures:

Financial: Susan Marie is an Associate Professor for Oregon Health & Science University. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Susan Marie has no relevant non-financial relationship to disclose.


Objectives

  1. Describe the expanding role of the mental health clinician in issues related to clients’ psychotropic medication use.
  2. Analyze the actions, therapeutic uses, and side effects of antidepressants.
  3. Explain how to recognize problematic prescribing patterns related to benzodiazepines and what can be done to resolve them.
  4. Summarize effective strategies for improving outcomes of clients taking mood stabilizers.
  5. Determine how to help clients manage possible side effects of antipsychotic medications.
  6. Explore psychotropic medication treatment options for clients with Attention Deficit/Hyperactivity Disorder.
  7. Contrast the benefits and risks of using hypnotics vs. alternative treatment options for sleep disorders.
  8. Determine how to effectively incorporate medication treatment options for substance use disorders into an overall plan of care.
  9. Communicate the efficacy of psychotropic medications in treating eating disorders and how to integrate their use with psychotherapy.
  10. Evaluate the unique medication treatment considerations for geriatric clients.
  11. Scrutinize the use of psychopharmacology interventions for women’s health issues in light of the current evidence.
  12. Ascertain the effectiveness of complementary and alternative agents for treatment of psychiatric conditions.

Outline

THE VITAL, AND EXPANDING, ROLE OF THE MENTAL HEALTH CLINICIAN IN PSYCHOPHARMACOLOGY

  • Understand, and explain, drug metabolism and mechanism of action
  • Recognize when to refer for medication, and how to increase client interest and participation
  • Develop highly effective collaborations with prescribers

WHAT THE MENTAL HEALTH CLINICIAN NEEDS TO KNOW ABOUT

Depressive Disorders

  • Neurochemistry of depression
  • Controversy regarding antidepressants and placebo – Who to treat when?
  • Types of antidepressants – pearls and pitfalls of different agents
  • Managing side effects
  • Treatment-Resistant Depression and drug combinations

Anxiety, Obsessive-Compulsive, & Trauma-Related Disorders

  • Neurochemistry of anxiety
  • SGAD, panic disorder, phobias
  • OCD
  • PTSD
  • Physiological interventions
  • Anti-anxiety medications
    • Antidepressants
    • The many other options often ignored
  • Benzodiazepines: risks and benefits
    • How to recognize problematic prescribing patterns
    • Getting off benzos: key pearls for success
  • Managing side effects

Bipolar Disorders

  • Neurochemistry and symptoms
  • The Bipolar Spectrum concept & DSM-5® changes
  • Types of mood stabilizers, when to use which and potential adverse effects
    • Lithium
    • Anticonvulsants
    • Atypical antipsychotics
    • Augmenting agents
  • Effective strategies for improving outcomes for clients
  • Using blood levels effectively – what the prescriber may not be watching
  • Treating pregnant or potentially pregnant women with bipolar disorder

Psychotic Disorders/Schizophrenia

  • Neurochemistry of psychosis and schizophrenia
  • Antipsychotic Medications:
    • First generation (typical)
    • Second generation (atypical)
  • Managing side effects
    • Extrapyramidal symptoms and TD
    • Metabolic problems – what blood tests are needed and when
    • Preventing Diabetes Mellitus
  • Recognizing hyperprolactinemia – and why you need to know
  • Use of atypical antipsychotics for multiple disorders
  • Pregnancy and psychotic disorders

Attentional Disorders

  • Differential diagnosis
  • Neurochemistry of ADHD
  • Controversy about treatment of ADHD with stimulants
  • Substance abuse and ADHD
  • Stimulant medications
  • Non-stimulant options
  • Managing side effects

Sleep Disorders

  • Differential diagnosis
  • Chicken or the egg? What came first, sleep problems or mental illness?
  • Controversy about treating sleep problems with hypnotics
  • Sleep interventions that really work
  • Hypnotic medications: risks and benefits
  • Alternatives to hypnotics
  • Recognizing adverse effects

Substance Use Disorders

  • Neurochemistry of addiction & habit development
  • Drugs of abuse and interaction with psychiatric medications
    • Caffeine
    • Nicotine
  • Marijuana (discussion of medical marijuana, cost vs. benefit)
  • Others
  • Challenging the old thinking about when to prescribe for clients with dual diagnosis – what we now know
  • Medication assisted treatments for addictions
    • Alcohol
    • Nicotine
    • Cannabis
    • Opiates
  • Behavioural addictions – what we know works

Eating Disorders

  • Anorexia, bulimia, binge eating disorder
  • Weight gain from psychotropic medications
  • Recognizing medical emergencies
    • Standard of care for lab work
  • Integrating psychotherapy with psychopharmacology

Special Populations: Geriatric

  • Specialized guidelines for geriatric clients
  • Discussion of dementia treatment
  • Antipsychotic controversy

Special Populations: Women

  • Hormonal issues in mood disorders & anxiety
  • Pregnancy and breastfeeding - Presenting the choices
  • Resources for you and your clients
  • The dangerous, the concerning, and the possibly good options for psychopharmacology

Use of Complementary and Alternative Agents Across Psychiatric Conditions

  • Safety issues
  • Proven efficacy and dosin

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Case Managers
  • Marriage and Family Therapists
  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Addiction Counselors
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Psychiatrists
  • Other Mental Health & Healthcare Professionals

Please wait ...

Back to Top